Abdominal Obesity Linked to Recurrent Atherosclerotic CVD
Abdominal obesity is associated with an increased risk for recurrent atherosclerotic cardiovascular disease after myocardial infarction.
Cardiovascular and Metabolic Disorders
Triglyceride Reduction May Improve Quality of Life in Patients With Familial Chylomicronemia Syndrome
Reduction of triglycerides with volanesorsen therapy may significantly improve the clinical symptoms and quality of life in patients with familial chylomicronemia syndrome.
Diabetes Is an Independent Risk Factor for Heart Failure
Researchers assessed the long-term effect of diabetes on risk for the development of heart failure.
Tool Developed to Assess Long-Term CVD Risk, Benefit of Lipid-Lowering Intervention
The blood levels of non-high density lipoprotein cholesterol were found to have a strong association with the long-term risk for a cardiovascular disease event.
Lifestyle Intervention Improves Cardiometabolic Risk Factors in Women With PCOS
Researchers performed a systematic review and meta-analysis to summarize and update the evidence regarding the effects of lifestyle intervention, including diet, on cardiometabolic risk among overweight and obese women with PCOS.
Semaglutide Approved to Reduce Risk for Major Adverse Cardiovascular Events
The FDA has approved a new indication for Ozempic (semaglutide; Novo Nordisk) injection to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
Trial Evaluating Fish Oil-Derived Drug for MACE Risk Reduction Discontinued
AstraZeneca is discontinuing a phase 3 trial evaluating Epanova (omega-3 carboxylic acids) in patients with mixed dyslipidemia who are at high risk of cardiovascular disease (CVD), as findings from the study showed the treatment was unlikely to be beneficial.
Metabolic Syndrome Linked to Greater VTE Risk in Deep Vein Thrombosis
All components of metabolic syndrome were linked to greater risk for recurrent venous thromboembolism.
Lower Target for LDL-C Levels Reduces Risk for Cardiovascular Events After Stroke
High-intensity statin treatment after ischemic stroke or transient ischemic attack is associated with a reduced risk for subsequent cardiovascular events.
HbA1c Minimally Improves CVD Risk Prediction in Patients With, Without Diabetes
Inclusion of hemoglobin A1c as a factor in cardiovascular disease risk prediction scores only had modest benefit.
Next post in Diabetes
